GO:0006595 polyamine metabolic process: Metabolic Shielding Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006595 polyamine metabolic process describes the chemical reactions and pathways involving polyamines, organic compounds that contain two or more amino groups.
• Polyamines such as putrescine, spermidine and spermine are essential for cell growth, proliferation, differentiation and survival, and their intracellular levels are tightly controlled.
• Dysregulated polyamine metabolism is a hallmark of many cancers and contributes to tumor initiation, progression and therapy resistance.
• Polyamines influence diverse processes including alternative splicing, helper T cell lineage fidelity, lysosomal export, iron homeostasis and ferroptosis suppression.
• Dietary and pharmacological strategies that deplete polyamines can reprogram tumor cells and sensitize them to therapy, as shown in neuroblastoma models.
• CRISPR-based knockout, point mutation, knock-in and overexpression models are powerful tools to dissect causal roles of polyamine pathway genes in health and disease.
Description
Polyamines are small, positively charged organic molecules that contain two or more amino groups and are indispensable for fundamental cellular processes such as DNA replication, transcription, translation and cell proliferation. The Gene Ontology term GO:0006595, polyamine metabolic process, captures the entire set of chemical reactions and pathways that build, modify, interconvert and degrade these molecules within a cell. Because polyamine levels must be maintained within a narrow window, their metabolism is subject to multiple layers of regulation, and its perturbation is linked to cancer, immune dysfunction, neurodegeneration and metabolic disease. For researchers, GO:0006595 provides a structured framework to annotate genes, interpret omics data and design experiments that test how individual enzymes and transporters shape cellular polyamine pools. Recent studies have expanded the known functions of polyamines beyond classical growth control, revealing roles in alternative splicing, lysosomal export, iron buffering and ferroptosis suppression. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of polyamine metabolic process, its key genes, disease connections and experimental strategies.
polyamine metabolic process At A Glance
| GO ID | GO:0006595 |
|---|---|
| GO term | polyamine metabolic process |
| Ontology | biological_process |
| Synonym | polyamine metabolism |
| Definition | The chemical reactions and pathways involving polyamines, any organic compound containing two or more amino groups. |
| Major function | Biosynthesis, interconversion, catabolism, transport and homeostasis of putrescine, spermidine and spermine. |
| Key enzymes | ODC1, SRM, SMS, SAT1, PAOX, AZIN1, AMD1. |
| Key transporters | ATP13A2, SLC3A2, SLC7A1. |
| Associated processes | Cell proliferation, differentiation, autophagy, ferroptosis suppression, alternative splicing, immune cell fate. |
| Disease relevance | Cancer, neurodegeneration, immune disorders, metabolic disease. |
What Is GO:0006595?
GO:0006595 polyamine metabolic process is defined by QuickGO as the chemical reactions and pathways involving polyamines, any organic compound containing two or more amino groups. In practice, this term encompasses the biosynthesis of putrescine, spermidine and spermine from amino acid precursors, their interconversion and catabolism, and the transport and compartmentalization events that determine their availability within cells. The term is a biological process and is often used to annotate enzymes such as ornithine decarboxylase (ODC1), spermidine synthase (SRM), spermine synthase (SMS), and catabolic enzymes including spermidine/spermine N1-acetyltransferase (SAT1) and polyamine oxidase (PAOX). It also applies to regulatory proteins and transporters that control polyamine flux, such as ATP13A2, which mediates lysosomal polyamine export.
Why Is polyamine metabolic process Important in Cell Biology?
Polyamine metabolic process is important because polyamines are required for essentially all steps of gene expression and cell growth, yet their excess is toxic and can drive oncogenesis. Consequently, cells invest heavily in regulating polyamine synthesis, catabolism and transport, and disruption of this balance is associated with cancer, immune dysfunction and neurodegeneration. Understanding GO:0006595 therefore provides a mechanistic entry point for therapeutic strategies that target polyamine metabolism, including inhibitors of biosynthesis and dietary interventions that deplete polyamines.
• Polyamines are essential for DNA stability, transcription, translation and cell proliferation.
• Altered polyamine metabolism is a metabolic hallmark of many cancers and supports tumor growth and survival.
• Polyamine levels influence helper T cell lineage fidelity and immune responses.
• Polyamines buffer labile iron and suppress ferroptosis, linking them to cell death regulation.
• Lysosomal polyamine export mediated by ATP13A2 is critical for neuronal function and is linked to neurodegeneration.
• Polyamine-dependent metabolic shielding regulates alternative splicing, expanding the functional repertoire of polyamines.
• Diet-enhanced polyamine depletion can reprogram neuroblastoma and improve therapeutic outcomes in preclinical models.
• Targeting polyamine metabolism offers opportunities for cancer therapy and chemoprevention.
• Polyamine metabolism intersects with autophagy, mTOR signaling and mitochondrial function.
• CRISPR models enable causal testing of polyamine pathway genes in disease contexts.
What Happens During polyamine metabolic process?
Biosynthesis of putrescine, spermidine and spermine
In simple terms: Cells build polyamines from amino acids through a series of enzymatic steps.
Polyamine biosynthesis begins with the conversion of ornithine to putrescine by ornithine decarboxylase (ODC1), the rate-limiting enzyme of the pathway. Putrescine is then converted to spermidine by spermidine synthase (SRM) using decarboxylated S-adenosylmethionine (dcSAM) as an aminopropyl donor, and spermidine is further converted to spermine by spermine synthase (SMS). The production of dcSAM is catalyzed by S-adenosylmethionine decarboxylase (AMD1), which is tightly regulated in concert with ODC1. These reactions ensure adequate supply of polyamines for growth and proliferation.
Catabolism and interconversion
In simple terms: Cells can also break down or recycle polyamines to prevent them from reaching toxic levels.
Polyamine catabolism is initiated by spermidine/spermine N1-acetyltransferase (SAT1), which acetylates spermidine and spermine, targeting them for oxidation by polyamine oxidase (PAOX) or spermine oxidase (SMOX). This back-conversion pathway generates putrescine and spermidine, and produces hydrogen peroxide and aldehydes as byproducts. The balance between biosynthesis and catabolism determines the size and composition of the intracellular polyamine pool.
Transport and compartmentalization
In simple terms: Polyamines must be moved into and out of organelles and cells to reach their sites of action.
Polyamines are transported across membranes by dedicated transporters and pumps. ATP13A2 mediates lysosomal polyamine export, and its deficiency disrupts lysosomal function and polyamine homeostasis. Other transporters, including SLC3A2 and SLC7A1, contribute to polyamine uptake and distribution. Compartmentalization allows polyamines to participate in organelle-specific functions, such as lysosomal iron handling and mitochondrial metabolism.
Polyamine-dependent metabolic shielding and alternative splicing
In simple terms: Polyamines can protect and regulate RNA processing under stress.
Recent work shows that polyamines can bind RNA and influence alternative splicing, a phenomenon termed polyamine-dependent metabolic shielding. This function links polyamine metabolism to the regulation of gene expression at the post-transcriptional level and may help cells adapt to metabolic stress. The discovery expands the classical view of polyamines as simple growth-promoting molecules.
Polyamines, iron homeostasis and ferroptosis
In simple terms: Polyamines help control iron so that cells do not undergo a specific type of cell death called ferroptosis.
Polyamines buffer labile iron and thereby suppress ferroptosis, a form of iron-dependent cell death. This function connects polyamine metabolism to redox biology and cell survival under oxidative stress. It also suggests that manipulating polyamine levels could influence ferroptosis sensitivity in cancer and other diseases.
Key Genes Involved in GO:0006595 polyamine metabolic process
The following genes encode enzymes, transporters and regulators that are central to polyamine metabolic process (GO:0006595) and are frequently studied in cancer, immunology and neuroscience research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ODC1 | Rate-limiting enzyme converting ornithine to putrescine | Target for cancer therapy; knockout reduces polyamine levels |
| AMD1 | Produces decarboxylated SAM for spermidine and spermine synthesis | Regulates polyamine flux; linked to cancer and stemness |
| SRM | Converts putrescine to spermidine | Essential for spermidine production; knockout affects growth |
| SMS | Converts spermidine to spermine | Spermine synthesis; implicated in neurological disorders |
| SAT1 | Acetylates spermidine and spermine for catabolism | Key catabolic enzyme; regulates polyamine pool size |
| PAOX | Oxidizes acetylated polyamines | Generates hydrogen peroxide; linked to oxidative stress |
| SMOX | Oxidizes spermine to spermidine | Produces reactive oxygen species; role in inflammation |
| AZIN1 | Antizyme inhibitor; stabilizes ODC1 | Regulates ODC1 stability and polyamine synthesis |
| OAZ1 | Antizyme; targets ODC1 for degradation | Feedback regulator of polyamine biosynthesis |
| ATP13A2 | Lysosomal polyamine exporter | Deficiency causes lysosomal dysfunction and neurodegeneration |
| SLC3A2 | Polyamine transport subunit | Influences polyamine uptake and drug sensitivity |
| SLC7A1 | Polyamine transport subunit | Contributes to polyamine homeostasis |
| EIF5A | Translation factor activated by spermidine-derived hypusination | Links polyamines to protein synthesis |
| DHPS | Enzyme required for hypusination of EIF5A | Spermidine-dependent translation regulation |
| DOHH | Enzyme required for hypusination of EIF5A | Spermidine-dependent translation regulation |
| TP53 | Tumor suppressor that modulates polyamine metabolism | Loss alters polyamine pathway gene expression |
| MYC | Oncogene that drives polyamine biosynthesis | Amplification increases ODC1 and polyamine flux |
| MTOR | Kinase that promotes polyamine synthesis | Links growth signaling to polyamine metabolism |
How Is polyamine metabolic process Regulated?
Polyamine metabolic process is regulated at multiple levels to maintain intracellular polyamine homeostasis. The rate-limiting enzyme ODC1 is controlled by antizyme (OAZ1)-mediated degradation and by antizyme inhibitor (AZIN1), which stabilizes ODC1. mTOR signaling promotes polyamine synthesis by increasing ODC1 expression and activity, coupling growth signals to polyamine demand. Feedback regulation by polyamines themselves inhibits ODC1 translation and activates antizyme, while SAT1 and PAOX are induced in response to excess polyamines to promote catabolism. Additionally, ATP13A2-mediated lysosomal export provides a compartmentalized mechanism to regulate cellular polyamine levels. These layers ensure that polyamine concentrations remain within a narrow physiological range.
polyamine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ODC1 | Cancer (e.g., neuroblastoma, colorectal cancer) | Knockout and overexpression cell lines; xenograft models |
| ATP13A2 | Neurodegeneration (Kufor-Rakeb syndrome, Parkinson's disease) | Knockout iPSC-derived neurons; point-mutation knock-in |
| SAT1 | Cancer and oxidative stress | Knockout and point-mutation models to study catabolism |
| MYC | Cancer (multiple types) | Overexpression and knockout models to link oncogene to polyamine flux |
| EIF5A | Translation regulation and cancer | Hypusination-deficient point mutants; knockout |
Polyamine metabolism in cancer
Dysregulated polyamine metabolism is a well-established feature of many cancers, where oncogenes such as MYC drive increased polyamine biosynthesis to support proliferation and survival. High polyamine levels are associated with tumor progression, metastasis and resistance to therapy, making the pathway an attractive therapeutic target. Inhibitors of ODC1, such as difluoromethylornithine (DFMO), and polyamine transport inhibitors have been explored in preclinical and clinical studies. Recent work shows that diet-enhanced polyamine depletion can reprogram neuroblastoma cells and sensitize them to treatment, highlighting the potential of metabolic interventions.
Polyamine metabolism in immune cell function
Polyamine metabolism is a central determinant of helper T cell lineage fidelity, influencing differentiation and effector functions. Manipulating polyamine levels can alter T cell responses, with implications for autoimmunity, infection and cancer immunotherapy. This connection underscores the importance of polyamine homeostasis in immune regulation.
Polyamine metabolism in neurodegeneration
ATP13A2 deficiency disrupts lysosomal polyamine export and is linked to neurodegenerative disorders such as Kufor-Rakeb syndrome and Parkinson's disease. Impaired polyamine homeostasis may contribute to lysosomal dysfunction and neuronal death. These findings position polyamine metabolism as a potential target for neuroprotective strategies.
Polyamines, iron and ferroptosis
Polyamines buffer labile iron and suppress ferroptosis, a form of cell death implicated in cancer, neurodegeneration and ischemia-reperfusion injury. This function links polyamine metabolism to redox balance and cell survival, suggesting that modulating polyamines could influence ferroptosis-related diseases.
From polyamine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ODC1 reduce tumor growth? | ODC1 knockout cancer cell lines and xenografts |
| How does ATP13A2 deficiency affect lysosomal polyamine export? | ATP13A2 knockout iPSC-derived neurons |
| Does a specific point mutation in SAT1 alter polyamine catabolism? | SAT1 point-mutation knock-in cell lines |
| Can polyamine depletion reprogram neuroblastoma? | Diet-enhanced polyamine depletion in neuroblastoma models |
| What is the role of EIF5A hypusination in translation? | EIF5A hypusination-deficient knock-in models |
| How do polyamines regulate alternative splicing? | Polyamine pathway knockout cells combined with RNA-seq |
How to Study the polyamine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Absolute levels of putrescine, spermidine, spermine | Validating knockout or inhibitor effects |
| RNA-seq | Gene expression and alternative splicing changes | Identifying polyamine-regulated pathways |
| Ribo-seq | Translation efficiency | Assessing EIF5A hypusination effects |
| Western blot | Protein levels of ODC1, SAT1, EIF5A | Confirming pathway perturbations |
| Immunofluorescence | Subcellular localization of polyamine enzymes | Studying lysosomal export and compartmentalization |
| CRISPR knockout screening | Gene essentiality and pathway dependencies | Discovering polyamine-related vulnerabilities |
| Ferroptosis assays | Lipid peroxidation and cell death | Testing polyamine-iron interactions |
| Hypusination detection | EIF5A modification status | Linking spermidine to translation |
Metabolomics and polyamine quantification
Mass spectrometry-based metabolomics allows direct measurement of putrescine, spermidine and spermine levels in cells and tissues. These methods are essential to confirm that genetic or pharmacological perturbations actually alter polyamine pools.
Transcriptomics and RNA-seq
RNA sequencing can reveal how polyamine pathway perturbations affect global gene expression, including alternative splicing events linked to polyamine-dependent metabolic shielding. Comparing knockout and wild-type cells identifies downstream pathways controlled by polyamines.
Proteomics and post-translational modification analysis
Proteomics can assess protein-level changes in polyamine enzymes and detect hypusination of EIF5A, a spermidine-dependent modification required for translation. These approaches link polyamine metabolism to protein synthesis and cellular stress responses.
Imaging and subcellular localization
Fluorescent probes and tagged proteins enable visualization of polyamine distribution and organelle-specific functions, such as lysosomal export by ATP13A2. Imaging can also monitor ferroptosis and iron handling in polyamine-manipulated cells.
How CRISPR Can Be Used to Study GO:0006595 polyamine metabolic process
Knockout
CRISPR knockout of polyamine pathway genes such as ODC1, SRM, SMS, SAT1 and ATP13A2 enables researchers to test their causal roles in cell growth, survival and disease phenotypes. Knockout cell lines can be used for metabolomic, transcriptomic and drug-sensitivity studies.
Point Mutation
Point-mutation knock-in models allow precise interrogation of catalytic residues or regulatory sites in polyamine enzymes, such as ODC1 or SAT1. These models help distinguish enzymatic activity from scaffolding functions and can mimic disease-associated variants.
Knock-in
Knock-in of tagged or reporter alleles (e.g., GFP-ODC1 or luciferase-SAT1) facilitates real-time tracking of protein localization, stability and response to polyamine levels. Knock-in of disease-relevant mutations, such as ATP13A2 variants, can model neurodegeneration.
Overexpression
Overexpression of polyamine biosynthetic enzymes, such as ODC1 or AMD1, can drive increased polyamine flux and model oncogenic states. Overexpression models are useful for testing whether elevated polyamine metabolism is sufficient to promote proliferation or therapy resistance.
How EDITGENE Supports polyamine metabolic process Research
Researchers studying polyamine metabolic process-related genes often need to determine whether a candidate gene is causally involved in polyamine homeostasis, cell growth or disease phenotypes. CRISPR-based models provide a rigorous way to manipulate these genes and measure the consequences on polyamine levels, downstream pathways and cellular behavior.
Contact EDITGENE today to design your custom CRISPR model for polyamine metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ODC1 Knockout HEK293 Cell Line | EDJ-KQ943 | Human | 4953 | Details Get a Quote |
| OAZ2 Knockout HEK293 Cell Line | EDJ-KQ5372 | Human | 4947 | Details Get a Quote |
| SRM Knockout HEK293 Cell Line | EDJ-KQ5848 | Human | 6723 | Details Get a Quote |
| ODC1 Knockout A-549 Cell Line | EDJ-KQ19926 | Human | 4953 | Details Get a Quote |
| ODC1 Knockout HCT 116 Cell Line | EDJ-KQ19927 | Human | 4953 | Details Get a Quote |
| ODC1 Knockout HeLa Cell Line | EDJ-KQ19928 | Human | 4953 | Details Get a Quote |
| SRM Knockout A-549 Cell Line | EDJ-KQ28050 | Human | 6723 | Details Get a Quote |
| OAZ2 Knockout A-549 Cell Line | EDJ-KQ28504 | Human | 4947 | Details Get a Quote |
| OAZ2 Knockout HCT 116 Cell Line | EDJ-KQ28505 | Human | 4947 | Details Get a Quote |
| OAZ2 Knockout HeLa Cell Line | EDJ-KQ28506 | Human | 4947 | Details Get a Quote |
| SRM Knockout HCT 116 Cell Line | EDJ-KQ29313 | Human | 6723 | Details Get a Quote |
| SRM Knockout HeLa Cell Line | EDJ-KQ29314 | Human | 6723 | Details Get a Quote |
| AMD1 Knockout HEK293 Cell Line | EDJ-KQ50114 | Human | 262 | Details Get a Quote |
| SMS Knockout HEK293 Cell Line | EDJ-KQ50641 | Human | 6611 | Details Get a Quote |
| AMD1 Knockout HeLa Cell Line | EDJ-KQ52605 | Human | 262 | Details Get a Quote |
Displaying Records 1 To 15 Of 22 Records
Frequently Asked Questions About polyamine metabolic process
What is polyamine metabolic process GO:0006595?
GO:0006595 is a Gene Ontology biological process term defined as the chemical reactions and pathways involving polyamines, any organic compound containing two or more amino groups.
What genes are involved in polyamine metabolic process?
Key genes include ODC1, AMD1, SRM, SMS, SAT1, PAOX, SMOX, AZIN1, OAZ1 and ATP13A2, which encode biosynthetic enzymes, catabolic enzymes and transporters.
Why are polyamines important for cells?
Polyamines are required for DNA stability, transcription, translation and cell proliferation, and they also regulate autophagy, ferroptosis and immune cell function.
How is polyamine metabolism linked to cancer?
Many cancers show increased polyamine biosynthesis driven by oncogenes such as MYC, and high polyamine levels support tumor growth and therapy resistance.
What is the role of ATP13A2 in polyamine metabolism?
ATP13A2 mediates lysosomal polyamine export, and its deficiency disrupts lysosomal function and is linked to neurodegeneration.
Can diet affect polyamine metabolism in cancer?
Preclinical studies show that diet-enhanced polyamine depletion can reprogram neuroblastoma cells and improve treatment responses.
How do polyamines suppress ferroptosis?
Polyamines buffer labile iron, reducing iron-dependent lipid peroxidation and thereby suppressing ferroptosis.
What experimental models are used to study polyamine metabolism?
Common models include CRISPR knockout and overexpression cell lines, point-mutation knock-ins, metabolomics, RNA-seq and ferroptosis assays.
What is polyamine-dependent metabolic shielding?
It is a recently described function in which polyamines regulate alternative splicing under metabolic stress.
How does spermidine affect translation?
Spermidine is required for hypusination of EIF5A, a modification essential for translation elongation.
Conclusion
GO:0006595 polyamine metabolic process encompasses the biosynthesis, catabolism, transport and regulatory mechanisms that maintain polyamine homeostasis, a process essential for cell growth, survival and immune function. Its dysregulation is implicated in cancer, neurodegeneration and metabolic disease, and recent discoveries have expanded its roles to alternative splicing, iron buffering and ferroptosis suppression. CRISPR-based models, combined with metabolomics and transcriptomics, provide powerful tools to dissect the causal contributions of polyamine pathway genes and to identify new therapeutic opportunities.
References
- 1. Zabala-Letona A et al.. 2026. Polyamine-dependent metabolic shielding regulates alternative splicing.. Nature 651(8106):819-828 PMID: 41535471
- 2. Casero RA Jr et al.. 2018. Polyamine metabolism and cancer: treatments, challenges and opportunities.. Nat Rev Cancer 18(11):681-695 PMID: 30181570
- 3. Cherkaoui S et al.. 2025. Reprogramming neuroblastoma by diet-enhanced polyamine depletion.. Nature 646(8085):707-715 PMID: 40993392
- 4. Schibalski RS et al.. 2024. The role of polyamine metabolism in cellular function and physiology.. Am J Physiol Cell Physiol 327(2):C341-C356 PMID: 38881422
- 5. van Veen S et al.. 2020. ATP13A2 deficiency disrupts lysosomal polyamine export.. Nature 578(7795):419-424 PMID: 31996848
- 6. Puleston DJ et al.. 2021. Polyamine metabolism is a central determinant of helper T cell lineage fidelity.. Cell 184(16):4186-4202.e20 PMID: 34216540
- 7. Sharma P et al.. 2026. Polyamines buffer labile iron to suppress ferroptosis.. Cell 189(18):5571-5589.e10 PMID: 42600612
- 8. Damiani E et al.. 2018. Polyamines and Cancer.. Methods Mol Biol 1694:469-488 PMID: 29080189
